@article{175676,
  keywords = {FDA, committees, learning, institutional design},
  author = {Matias Iaryczower and Nathan Canen},
  title = {Innovation Adoption by Committee: Evaluating Decision-Making in the FDA},
  abstract = {<p>The FDA is responsible for the approval of new drugs, biological products and medical devices in the United States. \&nbsp;As part of the approval process, the FDA relies on advisory committees, which provide independent advice from outside experts. We combine a structural approach with newly collected data from meetings{\textquoteright} transcripts to study the process of collective learning and policy recommendation in advisory committees. We quantify the effectiveness of advisory panels, and evaluate changes \&nbsp;to its institutional framework. We find that deliberation significantly increases the accuracy of decision-making. Changes in deliberation rules or committee membership do not uniformly improve outcomes.</p>},
  year = {2024},
}